a) Generelt På basis af data fra kontrollerede, kliniske undersøgelser vil det kunne forventes, at patienterne efter behandling med BOTOX får en uønsket hændelse med en hyppighed på 35% for blefarospasme, 28% for cervikal dystoni, 17% for infantil cerebral parese og 11% for primær hyperhidrosis i aksillerne.
a) General Based on controlled clinical trial data patients would be expected to experience an adverse reaction after treatment with BOTOX at the rates of 35% for blepharospasm, 28% for cervical dystonia, 17% for paediatric cerebral palsy and 11% for primary hyperhidrosis of the axillae.